Figure 106

Ethylenediamine tetraacetic acid (EDTA)-lead mobilization test in chronic renal failure of uncertain origin (A-C). In a study of 296 patients without history of lead exposure, the results of this test were abnormal in 15.4% (II) of patients with hypertension and normal renal function and in 56.1% of patients with renal failure of uncertain origin (in 44.1% of the patients without associated gout (III) and in 68.7% of the patients with associated gout (IV), respectively).

(Continued on next page)

0 0

Post a comment